Furthermore, Li et al. showed that Sennoside A relieved inflammation, ferroptosis, and impairments in cognition in aging mice that have Alzheimer’s disease by decreasing TRAF6 [47]. This evidence concerns the gene TRAF6 and early-onset autosomal dominant Alzheimer disease.